RxDoctor Payments Data

Jennifer Vittorio

Pediatric Transplant Hepatology · New York, NYNPI 1285880450

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $148,871 of the $181,652 with a category attached, or 82.0%. Mirum Pharmaceuticals, Inc. accounts for 91.8% of it on its own, with 5 other manufacturers making up the rest.

$181,652in general payments, 2019–2025

Across 192 payments — averaging $946.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mirum Pharmaceuticals, Inc.$167K
  • Albireo Pharma, Inc.$15K
  • Sobi, Inc$142
  • AstraZeneca$125
  • Madrigal Pharmaceuticals$98
  • Sanofi$53
$217,674in research payments, 2019–2025

Across 43 payments — averaging $5062.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mirum Pharmaceuticals, Inc.$179K
  • Albireo Pharma, Inc.$39K

What the payments were for

  • Consulting fees$148,87182%
  • Travel & lodging$28,13515%
  • Food & beverage$4,6453%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric transplant hepatology providers in New Yorkto place this figure against a meaningful peer group, so we don't.

Other pediatric transplant hepatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →